Aikaterini Chatzipli, PhD

Postdoctoral Fellow

Katerina received her PhD in Genetics from Cambridge University. After completing her PhD, she joined the Wellcome Sanger Institute (UK) as a Postdoctoral Fellow, where she worked on cancer evolution. She also modelled chromosomal catastrophes (e.g., chromothripsis) often seen in cancer, and contributed to the unraveling of their mechanisms (Maciejowski, Chatzipli, et al., Nature Genetics, 2020). Katerina held a joint appointment at Cambridge University where she taught Cell Biology modules to undergraduate Natural Sciences students as part of her Fitzwilliam College Bye-Fellowship. During her time at Harvard, Katerina, developed an interest in rare cancers and rare disease research. In the Lee Lab, she is developing methods for rare disease target identification and individualized therapies in collaboration with Dr. Timothy Yu supported by the Chan Zuckerberg Initiative.